BWX Technologies (BWXT), a leader in nuclear components for U.S. naval reactors and expanding into commercial nuclear applications, reports first-quarter 2026 results after market close on May 4, 2026. From what I see, this earnings release carries significant weight amid surging demand for nuclear energy solutions, driven by defense contracts and clean energy initiatives. Following a record 2025 with 18% revenue growth and Q4 non-GAAP EPS of $1.08 (beating estimates), the report will provide insight into progress toward full-year guidance. For investors, it offers a clear view of backlog conversion, margin trends, and commercial nuclear momentum—all critical factors influencing valuation in a sector set for expansion.
Wall Street anticipates first-quarter revenue of approximately $830 million, reflecting robust 20-23% year-over-year growth fueled by government operations (primarily naval nuclear propulsion) and commercial segments. EPS consensus sits at $0.92-$0.93, up slightly from $0.91 last year, with focus on non-GAAP figures excluding one-time items. Key metrics include adjusted EBITDA growth and updates to the multi-year backlog, recently at record levels.
BWXT has beaten EPS estimates in recent quarters, including Q4 2025's $1.08 versus $0.89 expected. Historically, the stock has shown mixed reactions: gains after Q3 2025 but dips post-Q4 despite beats, often tied to guidance perceptions. Investors eye confirmation of 2026 outlook amid supply chain and labor dynamics. To gauge how BWXT compares to peers, I checked it using Tickeron’s AI Screener.
Heading into earnings, sentiment is cautiously optimistic, buoyed by nuclear sector tailwinds and BWXT's strong 2025 finish. Shares have outperformed the aerospace-defense industry over the past year, reflecting backlog strength. Risks include execution on complex government contracts and commercial ramp-up delays. Post-earnings volatility could hinge on guidance alignment with consensus. One thing that stands out to me is how the stock's resilience ties directly to that record backlog.
In my research process, Tickeron’s AI Screener has become a go-to resource. This AI-powered stock and ETF discovery tool lets me filter the market using technical patterns, fundamentals, trends, volatility, and AI-driven signals. I customize scans by industry, market capitalization, technical indicators, price patterns, and performance metrics to pinpoint trade ideas, trending stocks, breakout candidates, and opportunities more efficiently than manual methods. It streamlines my workflow and helps uncover insights I might otherwise miss.
Following Q1 results, attention will shift to full-year 2026 guidance validation, with revenue targeted at $3.75 billion (high-teens growth) and non-GAAP EPS of $4.55-$4.70. Government Operations, representing the bulk of revenue, should benefit from naval nuclear propulsion demand, while Commercial Operations eyes nuclear fuel and microreactor progress. I’m watching this closely because commercial momentum could be a real differentiator.
Key watches include backlog evolution (recently record-high), adjusted EBITDA margins amid cost inflation, and free cash flow generation. Industry dynamics like U.S. nuclear policy support and international opportunities could provide tailwinds.
Upcoming catalysts encompass contract awards, regulatory updates for advanced reactors, and quarterly segment breakdowns. Balanced cost management will be crucial as supply chain pressures persist. In my view, this positions BWXT well if they execute effectively.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
BWXT moved below its 50-day moving average on June 24, 2026 date and that indicates a change from an upward trend to a downward trend. In of 41 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 69 cases where BWXT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BWXT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
BWXT broke above its upper Bollinger Band on June 17, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for BWXT entered a downward trend on June 18, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BWXT's RSI Oscillator exited the oversold zone, of 20 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on June 15, 2026. You may want to consider a long position or call options on BWXT as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for BWXT just turned positive on June 11, 2026. Looking at past instances where BWXT's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BWXT advanced for three days, in of 328 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BWXT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (15.015) is normal, around the industry mean (10.849). P/E Ratio (56.000) is within average values for comparable stocks, (92.779). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.079). Dividend Yield (0.005) settles around the average of (0.019) among similar stocks. P/S Ratio (5.714) is also within normal values, averaging (36.950).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of components and services to nuclear power industry
Industry AerospaceDefense